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Abstract 
 
Background: The roots of Dianthus thunbergii SS Hooper are used traditionally in South Africa for the treatment of 
diabetes, wounds, colic, chest complaints and cancer. This study was aimed at investigating the potential anti-proliferative 
activities of the D. thunbergii in mammalian cancer cell lines. 
Materials and Methods: Aqueous and ethanol extracts of D. thunbergii were tested in vitro on two cancer cell lines: 
human hepato-cellular carcinoma (HepG2) cells and murine insulinoma (INS-1) cells using the 3-(4,5-Dimethylthiazol-2-
yl) 2,5-diphenyltetrazolium bromide (MTT) and crystal violet cell viability assays, as well as live-cell fluorescence imaging 
microscopy. A tentative profiling of the aqueous extract was also carried out using liquid chromatography-mass 
spectrometry (LC-MS). 
Results: The aqueous extract (50-200µg/ml) exhibited significant (p<0.05) cytotoxicity in HepG2 cells (IC50<50 µg/ml), 
while also significantly (p<0.05) decreasing the viability of INS-1 cells (IC50=36.0 µg/ml), although no toxicity was evident 
in L6 myotubes. Hoechst 33342® and propidium iodide staining of INS-1 cells further revealed significant growth 
inhibition (p<0.001) of INS-1 cells by the aqueous extract. No meaningful toxicity was, however, obtained with the ethanol 
extract (IC50 = 204.0 µg/ml).  Non-targeted LC-ESI-TOF/MS analysis of the aqueous extract revealed the putative identities 
of main compounds present in the aqueous root extracts, including some that may contribute to its anti-proliferative action.  
Conclusion: Taken together, the results showed that the roots of D. thunbergii may represent a potential plant-based source 
of agents with anti-proliferative efficacy. 
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Abbreviations: HepG2- Human hepato-cellular carcinoma cells, MTT- 3-(4, 5-Dimethylthiazol-2-yl) 2,5-
diphenyltetrazolium bromide, LC-MS- Liquid chromatography-Mass spectrometry, INS-1- Murine insulinoma cells, ESI- 
Electrospray ionization, TOF- Time of flight, DMSO- Dimethyl sulphoxide, PI- Propidium iodide. 
 
 
Introduction 
 
 The effective treatment of cancer in humans and animals is commonly plagued by the fact that most synthetic 
chemotherapeutic agents present with a variety of toxic effects, mainly due to their non-selectivity in killing cells. There is, 
therefore, increasing attention towards development of natural products, especially of botanical origin, as novel 
prophylactic and therapeutic alternatives against cancer (Newman et al., 2003; Newman, 2008). Indeed, as much as 60% of 
currently used anticancer drugs have been isolated from plant sources over the past several decades (Gordaliza, 2007). It 
must be noted, however, that herbs themselves can be toxic, especially at high concentrations and frequent use, with the 
possibility of deleterious herb-drug interactions (Fong, 2002). Nevertheless, from drug discovery and development 
perspectives, current efforts are in favor of more effective, affordable, less toxic and more target-based natural compounds 
that tend to inhibit selected molecular markers important for cancer growth and/or metastases (NCI, 2008).  
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Being naturally-derived, plant products are better tolerated by normal mammalian cells than chemically-derived 
synthetic anticancer agents. In addition, plants are more readily available, more affordable and less likely to cause 
dependency compared to synthetic drugs (Mahady, 2001; Unnati et al., 2013). The anticancer mechanisms of action of 
plant-derived compounds include the inhibition of cellular proliferation during tumorigenesis or the induction of apoptosis 
in cancer cells (Lian et al., 2003). Others act by inhibiting telomerase activity (Baum et al., 2006) or enhancing the immune 
system (Chen et al., 2006). 
The Caryophyllaceae is a large family of flowering plants containing about 88 genera used traditionally in several 
ethnic communities of the world to treat several diseases. They are especially well known in Chinese traditional medicine 
for the treatment of a wide variety of ailments (Chandra and Rawat, 2015). In ethno-medicinal terms, members of this 
family are renowned for their anticancer activities which are believed to be due to their rich content of structurally diverse 
saponins, benzenoids, phenyl propanoids and organo-nitrogen compounds (Chandra and Rawat, 2015; Gevrenova et al., 
2014; Naghibi et al., 2014). Gevrenova et al. (2006) also reported the abundance of the group of glucuronide oleanane-
type triterpene carboxylic acid 3, 28-bidesmosides (GOTCAB) saponins in the Caryophyllaceae. The genus Dianthus, 
popularly called carnation, consists of over 300 species distributed throughout Asia, Europe, Africa and North America. 
About 16 of these, including Dianthus thunbergii are found growing in South Africa, especially in the eastern part of the 
country (Pooley, 1998). 
 In South Africa, D. thunbergii SS Hooper (Hooper, 1961) (also called ‘wild pink’ from the color of its flowers) is 
included in a published list of Xhosa plants from the Eastern Cape, South Africa (Russell et al., 1987; Dold and Cocks, 
1999). The mature plant is about 30 cm tall, possessing slender leaves, almost always opposed and with or without stipules. 
The flowers are pale pink with bracts about 4 cm long and blue grey leaves at the base. The root is the part most commonly 
used for medicinal purposes in the Eastern Cape Province of South Africa (Oyedemi et al., 2009). 
 The anti-cancer properties of some Dianthus species have been described in other studies. The ethanol extract of 
D. chinensis was found to suppress HepG2 cell viability and to induce apoptosis in these cells via a down-regulation of the 
expression of anti-apoptotic Bcl-2 and Bcl-XL proteins (Nho et al., 2012). D. caryophyllus was shown to inhibit the growth 
of human colon cancer cell lines due to its content of a glycosylated flavonol, Kaempferol triglycoside (Martineti et al., 
2010). To the best of our knowledge, there is as yet no record of any scientific evaluation of the anti-cancer properties of D. 
thunbergii. In the present study, we have examined the anti-proliferative potentials of extracts of D. thunbergii against two 
cancer cell lines: HepG2 and INS-1 cells, while also evaluating the possibility of its selectivity towards normal cells using 
normal rat skeletal muscle, L6 myotubes. The potential for herb-drug interactions was also determined in an in vitro assay 
of CYP 3A4 activity. In addition, we attempted an untargeted analysis to characterize the major compounds in the root 
extracts of D. thunbergii using HPLC-MS with a triple time-of-flight analyzer.  
 
Materials and Methods 
Plant material, collection and preparation of extracts 
  
Whole plant samples of D. thunbergii were obtained from localities within Alice and Grahamstown, Eastern Cape 
Province of South Africa in June 2015. Specifically, the plant can be found on the rocky flats between Army base and 
Gowies Kloof, Grahamstown, Eastern Cape, South Africa (33° 17.353´S 26° 36.944´E). The plant was identified and 
authenticated by Prof. D.S. Grierson and a voucher specimen was deposited at the Giffen herbarium, Department of 
Botany, University of Fort Hare, South Africa (Voucher number: CRY-2502). The roots were separated from the rest of the 
plant, washed in clean tap water and oven-dried at 30°C for 24 hours and milled with an electric blender (Commercial 
Blender type GB27, Hamilton Beach Brands, Inc. China) to coarse powder. The extraction was done by marceration of the 
plant material separately in distilled water or ethanol (99.99%). These were gently rotated on an orbital shaker (Labcon 
laboratory service Pty, South Africa) for 24 hours. Filtrates from the aqueous extract were dessicated for about 48 hours 
using a freeze dryer, after initial freezing in an acetone chilling machine at -40°C. The ethanol extract was concentrated 
using a rotary evaporator (Heidolph Laborata 4000, Heidolph instruments, GmbH & Co, Germany). The extracts were 
either dissolved in DMSO for cell culture experiments or the respective solvents as required.  
 
HPLC-MS analysis 
 
 Putative identification of metabolites in the aqueous extract of D. thunbergii was carried out using a high 
performance Agilent 1260 Infinity Liquid chromatography (LC) system, equipped with an AbSciex 5600 Triple TOF 
hybrid mass spectrometer (MS) (Applied Biosystems Sciex, USA) and operated in the negative electrospray ionization 
(ESI) mode. The LC system consisted of a 4.6 x 50 mm reverse phase column (ProShell 120; EC-C18) with diameter 7 μm. 
The mobile phase for gradient elution consisted of two solvents: Solvent A: Water with 0.1% formic acid and Solvent B: 
Acetonitrile with 0.1% formic acid. The linear elution gradient used for the elution of bound compounds was as follows: 
75% Solvent A (2 min), 75% Solvent A (6 mins), 25% Solvent A (4 min), 25% Solvent A (3 min) and 75% Solvent A (2 
min), giving a total run time of 17 minutes. The injection volume was 5.0 μl and the flow rate was 1 ml/minute. TOF-MS 
parameters were as follows: The Declustering potential (DP) was 60 V, while collision energy (CE) was 35 V.  
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Product ion parameters were as follows: Ion Spray voltage floating (ISVF): 4500; Ion Source Gas 1 (GS 1): 45 psi; 
Ion Source Gas 2 (GS 2): 45 psi and Temperature (TEM): 450. TOF masses were acquired using the Analyst Software for 
masses ranging from 100–1000 Da, while spectra were recorded in the ESI negative mode between m/z 50 and 1000. 
 For data treatment, XCMS online software (https://xcmsonline.scripps.edu) (Smith et al., 2006) was used for pre-
processing of all scanned data (3361 potential peaks) to extract potential molecular features, whose isotopic distribution 
were defined with peak spacing tolerance of m/z 0.01 and mass accuracy of 10 ppm. Adduct formation in negative mode 
using two ions (-H and +Cl) were included to identify features with same potential metabolites. The resulting molecular 
features (298 peaks) were tentatively identified by searching the MS and MS/MS information in the Food Database 
(http://foodb.ca/) Version 1.0, with an error limit of 5 ppm. 
 
Cell culture conditions 
  
HepG2 cells were purchased from Highveld Biological, (Johannesburg, South Africa). INS-1 cells were a gift 
from Prof Guy Ritter (University of Bristol, England). L6 cells were obtained from the Japanese Collection of Research 
Bioresources (JCRB) Cell Bank (Osaka, Japan). HepG2 cells and INS-1 cells were maintained in EMEM and RPMI 1640 
medium respectively, supplemented with 10% fetal bovine serum and sub cultured every 2-3 days in the presence of 
penicillin-streptomycin. L6 myoblasts maintained in DMEM supplemented with 10% fetal bovine serum were allowed to 
differentiate into myotubes by culturing the cells in 2% horse serum for 7 additional days. All cell cultures were incubated 
at 37°C in a humidified atmosphere with 5% CO2. 
 
MTT assay 
  
HepG2 cells were seeded at a density of 6 000 per well at a volume of 100 μl per well. The cells were treated by 
adding 100 μl of the aqueous and ethanol extracts of D. thunbergii prepared at final concentrations of 50, 100 and 200 
µg/ml in complete culture medium. The treatments were allowed for 48 hours at 37°C in a humidified 5% CO2 incubator, 
after which all spent media were removed by aspiration. The medium was replaced with 100 μl EMEM containing 10% 
fetal calf serum and 0.5 mg/ml MTT. The plates were gently rocked and then incubated at 37°C for 3 hours. At the end of 
incubation, the medium was aspirated and 200 μl of DMSO was added to solubilize the formazan crystals formed in the 
cells. The absorbance of the wells was read at 540 nm with a multi-plate reader (BioTek® PowerWave XS 
spectrophotometer). Concentrations of the extracts that were toxic to HepG2 cells were also tested in L6 myotubes using 
MTT assay as described. Cell viability was expressed as a percentage relative to the untreated control. 
 
Crystal violet assay 
  
INS-1 cells were seeded at a density of 8 000 cell/well in 96-well micro-titer plates with 100 μl of complete 
medium (RPMI 1640: 10% fetal bovine serum). Aqueous extracts of D. thunbergii suspended in DMSO (0.25%, v/v) were 
added to the wells already containing complete medium to reach concentrations of 12.5, 25 and 50 μg/ml of the extracts. 
The plates were incubated for about 48 hours at 37ºC in a humidified incubator and 5% CO2. DMSO (0.25%, v/v) served 
as the vehicle (untreated) control. All spent culture medium were removed and replaced with 100 μl of formaldehyde in 
PBS (10 %, v/v) to fix the cells. After about 1 hour, the fix solution was removed and 100 μl crystal violet solution (0.1%, 
w/v) was added to each well, followed by incubation of the plates at room temperature for about 30 minutes. Excess dye 
was removed by washing the plates with distilled water and the plates were dried by tapping on a paper towel. The dye 
taken up by the cells was extracted with 10% acetic acid (100 μl/ well). The absorbance of the wells was read at 595 nm 
using a BioTek® PowerWave XS spectrophotometer. Cell viability was expressed as a percentage relative to the untreated 
control. 
 
Hoechst® 33342 and Propidium iodide staining for live cell imaging 
 
INS-1 cells were maintained and treated as for the crystal violet assay with aqueous extracts of D. thunbergii 
(12.5–50µg/ml) with DMSO as control. Hoechst stock solution was prepared as a 10 mg/ml solution in distilled water. The 
stock solution was further diluted 1:2 in PBS to a working concentration of 5µg/ml. All medium was removed from the 
cultured cells and replaced with 100 μl of the Hoechst solution. The plates were incubated for about 20 minutes at room 
temperature (~ 24°C). Propidium iodide (PI) (50 μg/ml) was then added to the cells and incubated for 5 minutes before 
acquiring the images with a Molecular Devices ImageXpress® Micro XLS microscope (CA, USA) using the red and blue 
filters and 40× objective.  
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CYP 3A4 inhibition assay 
  
The ability of the aqueous extract to inhibit the activity of human cytochrome P450 reductase was determined 
using a Vivid® CYP 3A4 fluorescent screening kit consisting of CYP 3A4 Baculosomes® Plus reagent, reaction buffer, 
BOMR substrate, Red fluorescent standard, a regeneration system and NADP+. The assay is based on the metabolism 
(oxidation) of the BOMR substrates by the specific CYP 450 enzyme, in the presence of NADP+, into products that are 
highly fluorescent in aqueous solution. The assay was performed according to the manufacturer’s instructions. Briefly, 40 
μl of 2.5X solutions of the aqueous extract (100 µM), the positive control Ketoconazole (92 µM and 230 µM) and solvent 
control were added to respective wells of a 96-well plate in four replicates. 50 μl of the Master pre-mix (containing CYP 
3A4 Baculosomes® Plus reagent and Vivid® regeneration system in the Vivid® reaction buffer) was then added to each 
well, after which the plate was incubated for 10 minutes at room temperature to allow the test compounds and 
Ketoconazole to interact with the CYP 3A4 enzyme. The reaction was started by the addition of 10 μl of the 
substrate/NADP+ mixture. In an end-point assay format, the plate was incubated for 30 minutes at room temperature, after 
which the reaction was stopped by the addition of 50 μl of 0.5 M Tris base. The fluorescence was measured at an emission 
of 590 nm following excitation at 550 nm using a Biotek® Synergy MX fluorimeter. CYP 3A4 inhibition was calculated as 
a percentage relative to the solvent control as follows: % CYP 3A4 inhibition = 1 – (test fluorescence/average fluorescence 
of solvent control) X 100. 
 
Statistical analysis 
  
Values were expressed as mean ± standard deviation. Statistical analysis was carried out using Graph Pad prism 
Version 5.01 and the test of significance was done using Student’s t-test (two-tailed). Significant differences between 
controls and the test compounds were defined at p values ranging from p<0.001 to p<0.05. IC50 values were determined 
using MS Excel software. 
 
Results and Discussion 
Cytotoxicity of aqueous and ethanol extracts in HepG2 and INS-cells 
  
In this study, we investigated the anti-proliferative activities of D. thunbergii based on ethno-medicinal claims for 
its use in the treatment of cancer and evidence of reported cytotoxic activities reported for its closely related species. We 
employed different in vitro assays in different cell lines in order to establish preliminary data on the potential cytotoxic 
activities of the aqueous and ethanol extracts of D. thunbergii. 
 Rat insulinoma (INS-1) cells, a benign pancreatic cancer cell line and human hepato-cellular carcinoma (HepG2) 
cells, a largely malignant cell line, have been used to examine the cytotoxicity of D. thunbergii in this study. The viability 
of HepG2 cells exposed to the aqueous and ethanol extracts (50-200 µg/ml), as determined by MTT assay, is shown in Fig. 
1. Significant anti-proliferative activity against HepG2 cells was observed for the aqueous extracts, with IC50 predicted to 
be much less than the lowest concentration tested. The ethanol extract though showed very little toxicity (IC50 = 204.0 
µg/ml) to HepG2 cells and was thus eliminated from further study. According to the criteria by the American National 
Cancer Institute (Suffness and Pezzuto, 1990) for preliminary screening of cytotoxic crude plant extracts, promising 
candidates for further purification for anticancer therapy are those with IC50 ≤ 30 µg/ml, after exposure for at least 72 
hours. As the cells were exposed for only 48 hours in this study, the aqueous extract was considered promising for further 
cytotoxicity evaluation.  
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Figure 1: Dose response assay of cytotoxicity of aqueous and ethanol extracts of D. thunbergii in HepG2 cells, after 48 
hours exposure, as determined by MTT reduction. Data are expressed as % of control ± standard deviation (n = 4). DTA = 
Dianthus thunbergii aqueous extract; DTE = Dianthus thunbergii ethanol extract. The IC50 values of the extracts are: DTA 
(< 50 µg/ml) and DTE (204.0 µg/ml). 
 
Further assessment of cell viability was carried out in INS-1 cells, utilizing lower concentrations of the aqueous 
extract (12.5, 25 and 50 µg/ml), as it was obvious from MTT assay that concentrations lower than 50 µg/ml produced 
significant cell death. Results from crystal violet staining revealed a significant (p < 0.05) and concentration dependent 
decrease in the viability of INS-1 cells, with IC50 detected at 36.0 µg/ml (Fig. 2a). From the results of this study, cell 
viabilities at 50 µg/ml of the aqueous extract were 39.9±5.1% in INS-1 cells and only 12.5±0.5% in HepG2 cells. It may, 
thus, be reasonable to suggest that INS-1 cells may be more resistant than HepG2 cells to the cytotoxic effect of the extract.  
 
 
 
Figure 2: Viability of a) INS-1 and b) L6 cells after exposure to aqueous extract of D. thunbergii (for 48 hours). Values are 
expressed as mean (% of control) ± standard deviation (n = 8); UT = untreated control; DTA = Dianthus thunbergii 
aqueous extract; Glu = Glucose (11.1 mM). IC50 value for the extract is 36.0 µg/ml. * Significant differences at p < 0.05, 
compared to the untreated control. 
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Live cell imaging in INS-1 cells offered further confirmation of the cytotoxicity of the aqueous extract as revealed 
by the nuclear stains Hoechst and propidium iodide. Treatment of INS-1 cells with the aqueous extract produced marked 
growth inhibition of INS-1 cells with significant (p < 0.001) and concentration-dependent reduction in the percentage total 
cell counts of viable cells when compared to control values (Fig. 3). This was corroborated by significant (p < 0.05) 
increases in the percentage dead cell counts as revealed by propidium iodide. Hoechst® 33342 nucleic acid stain is a 
popular cell-permeant nuclear counter-stain that emits blue fluorescence when bound to dsDNA, while Propidium iodide 
(PI) is a popular red-fluorescent nuclear and chromosome counter-stain, and being non-permeant to live cells, it is used to 
detect dead cells in a population (Kelter et al., 2007), as presented in the images in Fig. 3. The results here further affirm 
the observations made with Crystal Violet assay in INS-1 cells. The consistent growth-inhibitory properties of this extract 
may, therefore, find application for controlling cancer progression, via reduction in cell proliferation. 
 
 
 
Figure 3: Image cytometry analysis of the anti-proliferative effects of the aqueous extract of D. thunbergii on INS-1 cells. 
Values in the charts are expressed as mean (% of control) ± standard deviation (n = 8). *Significant differences at p < 0.001 
(total cell counts) and p <0.05 (dead cells), compared to the untreated control (UT); DTA = Dianthus thunbergii aqueous 
extract; PI = Propidium iodide. 
 
Absence of Cytotoxicity in L6 myotubes and lack of CYP 3A4 inhibition 
  
The promise for practical application of the anti-proliferative potentials of a drug in cancer therapy depends on its 
ability to demonstrate considerable toxicity to cancer cells, while sparing non-cancerous cells (Lindholm et al., 2002; Hu et 
al., 2010). In addition, promising anticancer agents are required to demonstrate very little potentials for herb-drug 
interactions as frequent concomitant use of herbal products with conventional anticancer drugs by cancer patients may elicit 
adverse clinical effects or therapeutic failure due to the inhibition or induction of drug metabolism (Boullata et al., 2005; 
Chavez et al., 2006; Izzo and Ernst, 2009). In this study, MTT assay carried out on L6 myotubes revealed no alterations in 
percentage cell viabilities, when compared with the untreated control (Fig. 2b). The absence of toxicity to L6 myotubes 
suggest that the aqueous extract was not deleterious to normal cells However, it is important to also note that the L6 cells 
were confluent cultures (non-proliferating cells) and therefore, cytostatic effects may not be apparent.  
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Thus, it is important to clarify that the absence of any anti-proliferative effect in L6 cultures may not imply cancer 
cell specificity, but probably that the extract targets proliferating cells, which is a feature common to many of the current 
anti-cancer drugs. In effect, the promise of probable selective toxicity demonstrated by the extract requires further 
investigation. The potential for herb-drug interactions by D. thunbergii was examined by studying its effect on CYP 3A4, a 
CYP450 isoenzyme renowned for its involvement in the metabolism of up to 50% of currently prescribed drugs. Fig. 4 
shows the single point inhibitory effect of the aqueous extracts on the activity of CYP 3A4. The extract produced 27.5 ± 1.4 
% inhibition of the CYP 3A4, a value which was lower than that exhibited by both concentrations of the positive control, 
Ketoconazole. This result, in itself, suggests that aqueous extract may not likely produce significant interactions when 
administered concurrently with drugs metabolized by CYP 3A4. However, considering that Ketoconazole is a pure 
compound, compared to the crude extract and given that a concentration of 100 µg/ml used in this study, should be easily 
achieved as a practical dosage, the inhibition produced by the extract may well be considered physiologically relevant 
 
 
Figure 4: CYP 3A4 inhibitory activities of the aqueous extracts Dianthus thunbergii roots. Values are expressed as mean 
(% of control) ± standard deviation (n = 5) Ket = Ketoconazole; DTA = Dianthus thunbergii aqueous extract. 
 
 
Tentative identification of compounds in D. thunbergii roots 
  
Accurate mass measurements of metabolites using liquid chromatography (LC) coupled to electrospray ionization 
(ESI) techniques and time-of-flight mass spectrometry (TOF/MS) is widely accepted for verification of the elemental 
composition of compounds in complex matrices such as plant extracts (Lacorte and Fernandez-Alba, 2006; Heng et al., 
2013). These techniques incorporate high mass accuracy (< 5 ppm) which can provide initial or ‘putative’ identification of 
unknown peaks by searching metabolite databases (Prakash et al., 2007). As no previous studies exist on the chemical 
composition of D. thunbergii, we have attempted a tentative characterization of the aqueous extracts of D. thunbergii using 
LC-ESI-TOF/MS.  
 A total of fifty three metabolites were tentatively identified in the aqueous root extract using accurate mass 
measurements, and, where necessary the fragmentation patterns obtained in MS/MS spectra (Table 1). These have been 
classified into different families along with the main parameters that support their identification, including their masses 
(Da), m/z values (Da), retention times (minutes), adduct types and the delta values (ppm), which aided the selection of 
metabolites for peaks corresponding to different isomers. Figure 5 shows the MS total ion chromatogram of the analysis 
scanned in negative mode. The negative mode was selected as it is reported to be more sensitive in detecting polyphenols, 
especially flavonoids, and also has lower limits of detection (Fabre et al., 2001; De Rijke et al., 2003). Pre-processing was 
performed using the XCMS software which is currently the most widely used open source algorithm for defining molecular 
features from signatures of ionized metabolites (Smith et al., 2006; Tautenhahn et al., 2008). Among compounds identified, 
the majority of those with reported anti-proliferative activities were flavonoids and their derivatives as well as terpenoids 
(Table 1). 
 In total, 18 phenolic compounds were tentatively identified, including 13 flavonoids and flavonoid derivatives. Of 
these, 8 flavonoids were identified as the [M-H]- adduct form with high accuracy. These were 7-chloro-3,3´,4´,5,6,8-
hexamethoxyflavone (m/z 435.09), Irilone 4´-glucoside (m/z 459.09), Hyperoside (m/z 463.09), Myricetin 3(4´-acetyl 
rhamnoside) (m/z 505.10), 6´´-caffeoylastragalin (m/z 609.13), Kaempferol 3-gentiobioside (m/z 609.15),  
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alpha viniferin (m/z 677.18) and Peonidin 3-sophoroside 5-glucoside (m/z 786.22). Other phenolic compounds were in the 
family of lignans, phenolic glycosides, tannins and coumaric acid derivatives. Anti-proliferative effects have been attributed 
to hyperoside by Liu et al (2016) against lung cancer by inhibition of transcription of NF-κB transcriptional activity, 
activation of Caspase-9/Caspase-3 apoptotic pathway and cell cycle arrest. Alpha viniferin, a derivative of resveratrol, has 
been found to exhibit inhibitory properties against colorectal cancer via anti-inflammatory activities involving reduced 
expression of COX-2 and pro-apoptotic pro-apoptotic caspase-3 expression (Kwak et al, 2015). In addition, isoacteoside, a 
coumaric acid derivative, detected by the formation of the [M+Cl]- adduct at Rt 8.35 has been reported to exhibit anticancer 
properties (Wang and Nixon, 2001). 
 Terpenoid saponins are known for their anticancer properties and are found in rich quantities in the 
Caryophyllaceae (Gevrenova et al., 2014; Bottger and Melzig, 2010). It is remarkable, therefore, that a number of them 
were tentatively identified in the aqueous extract of D. thunbergii, including 4 triterpenes, 2 terpenoids and a 
monoterpenoid, all of which were detected in the chromatographic interval 9-12 minutes. Among these, Centellasaponin B 
(m/z 827.4435) was detected by the formation of the [M-H]- adduct at Rt 9.21 min. It is a triterpenoid glycoside belonging 
to the group of ursane- and oleanane-type triterpene oligoglycosides originally isolated from Centella asiatica (Matsuda et 
al., 2001). This compound, along with other related saponins, including centellasaponins C and D are believed to be 
responsible for the cytotoxic activities exhibited by Centella asiatica (Pitella et al., 2009)). Another triterpene saponin, 
Soyasaponin γg (m/z 957.46) was observed at Rt 9.76 by the formation of the [M+Cl]- adduct. This metabolite and a variety 
of other soyasaponins have been characterized in soy bean extracts and are reported to exhibit anti-mutagenic activities in 
Chinese hamster ovary cells (Berhow et al., 2000).  
 Other compounds, belonging to other families tentatively identified in the extracts were also found with reported 
anti-proliferative activities. The naphthoquinone, Neodiospyrin (m/z 409.05) detected as the [M+Cl]- adduct reportedly 
slows cancer metastasis by inhibiting 12(S)-HETE, a metabolite of 12-lipooxygenase (Wube et al., 2005). Mangiferin (m/z 
421.08) tentatively identified at Rt 7.24 as the [M-H]- is a xanthone, originally isolated from Mangifera indica and is 
known to exhibit promising anticancer properties (Khurana et al., 2016). Also, cytotoxic activities in HeLa cells have been 
reported for the alkaloid Bis (5-hydroxynoracronycine) (Weniger et al., 2001), which was tentatively identified in this study 
at Rt 3.02 as the [M+Cl]- adduct. Apart from the groups of compounds already discussed, our analysis also detected 
compounds in D. thunbergii roots, including lipids and lipid-like molecules, oligosaccharides, organo-heterocyclic 
compounds, organo-nitrogen and organo-oxygen compounds. However, most of these compounds have been poorly studied 
with regards to their anti-proliferative activities. 
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Figure 5: MS total ion chromatogram from the aqueous extract of D. thunbergii roots in negative ionization mode. 
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Table 1: Putative identification of compounds in the aqueous extracts of D. thunbergii showing the main parameters for their 
identification 
 
Class of 
compound 
 
 
Putative identification 
 
 
Mass 
 
 
m/z 
 
 
Adduct 
 
 
RT 
(min) 
 
 
δ 
(ppm) 
Previous report 
of anti-
proliferative 
activity  
Phenolic Compounds 
Flavonoids  
and derivatives 
 Peonidin 3-Sophoroside 
5-glucoside 
787.2297 786.2224 M-H 2.73 0.0002 
 
 
 
 Albanin H 840.3146 875.2674 M+Cl 2.86 0.0028 
 
 
 5’,8,8’’-Trihydrohy-
3’,3’’’,4’,4’’’,5’’’,7’,7’’-
heptamethoxy-5,5’’-
biflavan 
676.2520 711.2214 M+Cl 2.93 0.0000 
 
 
 
 
 
 Pelargonidin 3-
arabinoside 
403.1029 438.0723 M+Cl 7.37 0.0079 
 
 
 
 7-chloro-3,3’,4’,5,6,8-
hexamethoxyflavone 
436.0925 435.0852 M-H 7.45 0.0071 
 
 
 
 Isoeriotricin 596.1741 631.1435 M+Cl 7.53 0.0090 
 
 
 Alpha-Viniferin 678.1890 677.1817 M-H 7.79 0.0045 
 
[36] 
 Kaempferol 3-
gentiobioside 
610.1534 609.1461 M-H 7.90 0.0012 
 
 
 
 Hyperoside 464.0955 463.0882 M-H 8.48 0.0005 
 
 
[35] 
 Pinotin A aglycone 463.1029 498.0723 M+Cl 8.96 0.0011 
 
 
 Myricetin 3(4’-acetyl 
rhamnoside) 
506.1060 505.0988 M-H 9.37 0.0003 
 
 
 
 Irilone 4’-glucoside 460.1006 459.0933 M-H 10.24 0.0001 
 
 
 6’’-Caffeoylastragalin 610.1323 609.1250 M-H 11.04 0.0005 
 
 
Lignans 
 Lappaol H 750.2888 749.2815 M-H 6.56 0.0081 
 
 
Phenolic glycosides 
 Nb-trans-
Feruloylserotonin 
glucoside 
514.1951 549.1645 M+Cl 3.02 0.0033 
 
 
 
 
 Zeanoside C 385.1009 420.0703 M+Cl 7.44 0.0034 
 
 
Tannins 
 6-Cinnamoyl-1,6-
digalloyl-beta-D-
glucopyranose 
614.1272 613.1199 M-H 8.12 0.0041 
 
 
 
 
Coumaric acid  
41 
 
derivatives 
 Isoacteoside 624.2054 659.1748 M+Cl 8.35 0.0086 
 
[45] 
Terpenoids 
 Centellasaponin B 828.4507 827.4435 M-H 9.21 0.0014 
 
[40] 
 Alpha-Amyrin 
tetratriacontanoate 
916.8975 915.8903 M-H 9.53 0.0059 
 
 
 
 Soyasaponin gamma-G 922.4926 957.4620 M+Cl 9.76 0.0020 
 
[41] 
 Sanguisorbin E 792.4660 827.4354 M+Cl 9.95 0.0008 
 
 
 Auxin a 328.2250 327.2177 M-H 10.02 0.0003 
 
 
 Licorice saponin C2 806.4089 805.4089 M-H 10.44 0.0018 
 
[37] 
 Beta-Citraurin epoxide 448.2978 483.2672 M+Cl 11.37 0.0060 
 
 
Lipids and Lipid-like 
 molecules 
 Maltobionic acid 358.1111 357.1039 M-H 2.96 0.0000 
 
 
 Lactodifucotetraose 634.2320 633.2248 M-H 6.62 0.0002 
 
 
 Corchonisoside E 860.4042 895.3736 M+Cl 8.32 0.0065 
 
 
 Lactosamine 682.2644 681.2571 M-H 8.38 0.0090 
 
 
 Endomorphin-2 571.2795 606.2489 M+Cl 8.45 0.0045 
 
[46] 
 Lyciumin B 896.3817 895.3755 M-H 9.02 0.0046 
 
 
 Betavulganoside 1 954.4461 989.4155 M+Cl 9.44 0.0009 
 
 
 22-Deoxocurcubitacin D 502.3294 501.3222 M-H 12.22 0.0001  
Glycerophospholipids 
 PS (14:1(9Z)/14:1(9Z)) 675.4111 710.3805 M+Cl 9.98 0.0082 
 
 
 LPA(18:2(9Z, 12Z)/0:0) 434.2433 433.2361 M-H 11.77 0.0005 
 
 
Oligosaccharides 
 Maltohexose 990.3275 989.3202 M-H 2.83 0.0036 
 
 
 Inulin 504.1690 503.1618 M-H 2.99 0.0001 
 
 
Organo-heterocyclic  
compounds 
 Thiamine monophosphate 344.0708 379.0402 M+Cl 7.01 0.0055 
 
 
 
 Norrubrofusarin 6-
gentiobioside 
582.1585 617.1279 M+Cl 8.19 0.0087 
 
 
 
 3’-N-acetyl-4’-O-(9-
octadecenoyl) fusaro 
chromanone 
598.3982 633.3676 M+Cl 11.01 0.0022 
 
 
 
 
 1,3,5-Trihydroxy-10-
methyl acridone 
257.0688 256.0615 M-H 12.65 0.0005 
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 Citrusine II 287.0794 286.0721 M-H 12.88 0.0006 
 
 
 Cyanidin 3-(diferyloyl 
sophoroside) 5-glucoside 
274.2045 309.1739 M+Cl 13.46 0.0006 
 
 
 
Organo-nitrogen and  
Organo-oxygen  
compounds 
 Azimsulfuron  424.1026 423.0953 M-H 7.31 0.0011 
 
 
 4-Phenylbutyl 
glucosinolate 
451.0971 450.0898 M-H 7.50 0.0053 
 
 
 
 6’-Sialyllactosamine 632.2276 631.2203 M-H 8.63 0.0023 
 
 
 9-Decenoylcholine 256.2277 291.1971 M+Cl 11.10 0.0032  
Other classes 
 
Naphthoquinones 
 Neodiospyrin 374.0790 409.0484 M+Cl 6.78 0.0037 [42] 
Xanthones 
 Mangiferin 422.0849 421.0776 M-H 7.24 0.0036 [43] 
Diarylheptanoids 
 Kuwanon Y 582.1890 617.1584 M+Cl 7.47 0.0031 
 
 
Benzenoids 
 Aloinoside A 564.1843 599.1537 M+Cl 8.02 0.0091 
 
 
 N-
Undecylbenzenesulfonic 
acid 
312.1759 311.1686 M-H 11.82 0.0007  
Alkaloids        
 Bis (5-
hydroxynoracronycine) 
646.2315 681.2009 M+Cl 3.06 0.0098 
 
 
[44] 
RT = retention time in minutes; δ = delta value (Query mass – Adduct mass); m/z = mass-to-charge (adduct mass). For 
peaks with isomers, the metabolites with the lowest delta value were selected as their tentative identities. 
 
 
Conclusion 
 
 The current study proved the in vitro anti-proliferative activity of D. thunbergii aqueous root extract. The selective 
toxicity demonstrated by the extract suggests the plant may serve as a prospective material for the development of novel 
anti-proliferative agents against cancer cells. Profiling of compounds present in the extract by LC-TOF-MS tentatively 
revealed a total of 53 compounds, mainly on the basis of accurate mass measurements of the metabolites, while some 
compounds with reported anti-proliferative activities have been identified and discussed. However, more detailed analysis 
of the chemical composition of this plant is required for the confirmation of the actual identities of the unknown peaks via 
incorporation of retention time and/or mass spectral data of reference standards in further experiments. 
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